Beyond bortezomib alone: combination therapy and new strategies in targeting the proteasome.
Hematology Meeting Reports,
[S. l.], v. 1, n. 8, 2009. DOI:
10.4081/hmr.v1i8.291. DisponÃvel em:
https://journals.pagepress.org/hmr/article/view/291. Acesso em: 18 jul. 2025.